News

Mohbad’s Father Drags Primeboy, Others Before Coroner

Published

2 years ago

January 23, 2024

An application seeking to call more witnesses in the bid to unravel the cause of the death of the late singer, Ilerioluwa Aloba aka Mohbad, has been filed at the coroner court sitting in the Ikorodu area of Lagos State.

This was contained in a statement obtained by PUNCH Metro on Monday and signed by Monisola Odumosu of the Hillceetee Partners on behalf of the deceased’s father, Joseph Aloba.

In the application signed by Emmanuel Oroko. It was noted that the testimonies of the witnesses in the ongoing inquest would provide more factual, evidential, and better light on the circumstances leading to the death of the late singer.

The law firm said their research had shown “that there were incidents on the Third Mainland Bridge at about 2.30 am (Sunday, September 10, 2023), (which) the appropriate witnesses did not mention and which no one has related at the Coroner Inquest and in our opinion would have given away the circumstantial event that led to the death of Ilerioluwa Oladimeji Aloba.”

The application also revealed that there were events on September 12, 2023, at the deceased’s residence, which were not mentioned by the appropriate witnesses.

According to Odumosu, the application indicated that such information would have given a better insight into the real cause of the death of the deceased, adding that recent events had shown that some probable witnesses had been subpoenaed.

It added, “These key witnesses include the driver of the car that drove the deceased, his wife, his brother, and the witnesses proposed to the honourable inquest. Furthermore, the law firm believes that the situation of the CCTV at the deceased’s residential premises not functional at the time the deceased and others came home may not be true.”

The statement added that the witnesses requested to testify before the court include, “Ayobami Fisayo aka Spending, Boluwatife Adeyemo aka Darosha and Ibrahim Owodunni aka Prime Boy; all of whom were with the deceased at the material time.”

The law firm further asserted in the application that the evidence of these witnesses would help expound and give further clarity on the ongoing inquest in no small measure to understand the reasons and events leading to the death of the deceased.

“The application would also afford the inquest to make appropriate recommendations to the appropriate authority on who is culpable in the case.

“This would meet the justice of the case if the individuals proposed to be called could give their eyewitness accounts of the events that led to the death of Mohbad,” the statement added.

A source in the family told The PUNCH on Monday that the request came on the heels of the suspension of the ongoing inquest by the coroner.

The source who craved anonymity said, “We were surprised when we found out that the coroner had stopped sitting while waiting for the result of the pathologist. A pathologist is meant to investigate the cause of the death but there is still some circumstantial evidence which had been held on to and this would unravel the real cause of the death.”

Mohbad died on September 12 at the age of 27, with circumstances surrounding his death sparking controversies on social media.

Being a former record label signee of Marlian Music owned by Naira Marley, Mohbad left the label in February 2022.

The Lagos State Police Command had on September 18, 2023, inaugurated a 13-man special investigation team to probe the death.

His death also led to the arrest of Naira Marley, and controversial Lagos socialite, Balogun Eletu, aka Sam Larry, amongst others.

The body of Mohbad was on September 21, 2023, exhumed for autopsy to unravel the cause of his death.

The state Police Public Relations Officer, Benjamin Hundeyin, had tweeted in September 2023 that an “autopsy has been concluded” and the police were “awaiting result.”

In the course of its probe, the police declared Primeboy wanted on October 4, 2023, after which he turned himself in two days after.

Meanwhile, Aloba, in November 2023, had stated that nobody should collect his son’s body for burial without his authorisation.

In an interview with The PUNCH in December 2023, Hundeyin reiterated that the command had not received the report of the autopsy conducted on Mohbad from the pathologists.

News

Edo Targets 2.2 Million Children For Measles, Rubella Vaccination

Published

4 hours ago

January 8, 2026

Editor

The Edo State Government says it is targeting about 2.2 million children aged between 0 and 14 years for measles and rubella vaccination across the state.

The Director of Disease Control and Immunization at the Edo State Primary Health Care Development Agency, Dr. Eseigbe Efeomon, who disclosed this during stakeholders’ sensitisation meeting in Benin City, said this would be done in collaboration with development partners.

Efeomon, while noting that the vaccination exercise scheduled to hold simultaneously from January 20 to January 30, 2026, across the 18 local government areas of Edo State at designated health facilities and temporary vaccination posts, said the campaign aims to contribute significantly to the reduction of measles and rubella in Nigeria.

He explained that achieving this target requires increased population immunity through sustained vaccination.

Dr. Efeomon stressed that only qualified and certified health workers would be recruited as vaccinators because the vaccines are injectable.

According to him, the vaccination strategy would involve fixed posts and temporary fixed posts, and vaccination cards would be issued to all vaccinated children as proof, which parents and caregivers are advised to keep for future reference.

He added that vaccination teams would visit schools, churches, mosques, markets, motor parks, internally displaced persons’ camps and other public places, while children who receive the vaccine would be finger-marked to prevent double vaccination.

He reiterated that the overarching goal of the campaign is to drastically reduce rubella incidence nationwide and protect children from preventable diseases through effective immunisation coverage.

Also speaking, the World Health Organization Local Government Facilitator, Mr. Ajaero Paul, described measles and rubella as major causes of death and congenital abnormalities among children globally.

He said both diseases are preventable through the measles-rubella vaccine, which he described as safe and effective,

He added that sustained advocacy is critical to reducing child mortality and lifelong disabilities.

On his part, UNICEF Social and Behavioural Change Health Officer, Yakubu Suleiman, emphasised that the measles-rubella vaccine is safe and effective for all children aged nine months to 14 years.

He stated that the government has fully paid for the vaccines, making them available at no cost to all eligible children in government health facilities across the state.

Suleiman explained that vaccination not only protects individual children but also safeguards communities from deadly vaccine-preventable diseases such as measles and rubella.

He added that even children who had previously received the measles vaccine should still be given the measles-rubella vaccine and appealed to schools and other key stakeholders to support the campaign to ensure that no child is left behind.

News

Togo, Niger, Benin Owe Nigeria Over $17.8m For Supplied Electricity – NERC

Published

9 hours ago

January 8, 2026

Editor

Nigeria’s electricity regulator has disclosed that three neighbouring countries, Togo, Niger and Benin, are indebted to Nigeria to the tune of $17.8 million, equivalent to more than N25 billion at prevailing exchange rates, for power supplied under bilateral electricity agreements.

The Nigerian Electricity Regulatory Commission, NERC, made this known in its Third Quarter 2025 report, which reviewed market performance within the Nigerian Electricity Supply Industry, NESI.

According to the report, the international customers were billed a total of $18.69 million by the Market Operator for electricity supplied during the third quarter of 2025. However, only $7.125 million was paid, leaving an unpaid balance of $11.56 million for the period under review.

NERC also revealed that the same international offtakers had outstanding legacy debts amounting to $14.7 million from previous quarters. Of this amount, $7.84 million was settled, leaving a residual balance of $6.23 million.

When combined with the Q3 2025 shortfall, the total outstanding debt stood at $17.8 million, which translates to about N25.36 billion at an exchange rate of N1,425 to one US dollar.

The regulator identified the international electricity customers as Compagnie Énergie Électrique du Togo, Société Béninoise d’Énergie Électrique of Benin Republic, and Société Nigérienne d’Électricité of Niger Republic.

NERC stated that the three utilities collectively paid just $7.125 million against the $18.69 million invoice issued for electricity supplied in the third quarter, resulting in a remittance performance of 38.09 per cent.

This meant that more than half of the billed amount remained unpaid at the close of the quarter.

The commission explained that the electricity exported to the three countries was generated by grid-connected Nigerian generation companies and delivered through cross-border bilateral power supply arrangements.

By contrast, NERC reported a stronger payment performance among domestic bilateral customers. According to the report, local customers paid N3.19 billion out of the N3.64 billion invoiced for the same quarter, representing a remittance rate of 87.61 per cent.

The regulator further noted that some bilateral customers, both international and domestic, made additional payments to offset outstanding invoices from earlier quarters.

Specifically, the Market Operator received $7.84 million from international customers and N1.3 billion from domestic customers in settlement of previous obligations.

Beyond bilateral transactions, NERC disclosed that Nigeria’s 11 electricity distribution companies remitted a total of N381.29 billion to the Nigerian Bulk Electricity Trading Plc and the Market Operator in the third quarter of 2025. This was out of a cumulative invoice of N400.48 billion, translating to an overall remittance performance of 95.21 per cent.

The commission said the figures were derived from reconciled market settlement data submitted as of December 18, 2025, as part of its statutory evaluation of the commercial health and performance of the electricity market.

News

Expert Identify Foods That Increase Hypertension Medication’s Effectiveness

Published

16 hours ago

January 8, 2026

Editor

Hypertension remains one of the leading causes of premature death worldwide, contributing significantly to heart disease, stroke, and kidney failure. Despite the availability of effective antihypertensive drugs, long-term control of high blood pressure is often challenging because of drug resistance, side effects, and poor adherence.

This has fueled growing scientific interest in complementary strategies that can enhance drug efficacy while minimising toxicity. One promising approach is the combination of conventional antihypertensive medications with herbs and spices in many kitchens.

Recent evidence suggests that augmenting modern antihypertensive drugs with foods rich in p-coumaric acid, a naturally occurring phenolic acid, may offer a novel and effective strategy for blood pressure control.

Phenolic compounds, commonly found in fruits, vegetables, whole grains, and legumes, are known for their antioxidant, anti-inflammatory, and blood vessel–protective properties.

In a study, researchers investigated the combined effects of lisinopril, a widely used antihypertensive drugs and p-coumaric acid on hypertension.

They reported in the Comparative Clinical Pathology that p-coumaric acid enhance the antihypertensive action of lisinopril, potentially allowing for improved blood pressure control without increasing drug dosage.

The study used an established animal model in which hypertension was induced in rats through oral administration of L-NAME, a compound known to suppress nitric oxide production and raise blood pressure.

Following the induction of hypertension, the animals were treated for 14 days with p-coumaric acid (at two different doses), lisinopril alone, or a combination of both.

Untreated hypertensive rats showed significantly elevated activities of key enzymes linked to high blood pressure such as ACE, arginase, acetylcholinesterase, and phosphodiesterase-5 along with increased lipid peroxidation, an indicator of oxidative stress. At the same time, levels of nitric oxide, a critical molecule for blood vessel relaxation, were markedly reduced.

By contrast, rats treated with a combination of lisinopril and p-coumaric acid experienced notable improvements. Blood pressure was better controlled; harmful enzyme activities were reduced, oxidative stress declined, and nitric oxide levels increased. These improvements were mirrored in the tissues the heart compared with untreated hypertensive animals.

They said that the findings suggest that p-coumaric acid may enhance the antihypertensive action of lisinopril, potentially allowing for improved blood pressure control without increasing drug dosage.

This drug–food interaction model is particularly important in the circumstance of long-term hypertension management. Many patients rely on lifelong medication, and strategies that can improve treatment outcomes while reducing side effects are highly desirable.

The study also reinforces the growing recognition that diet is not merely supportive but can be biologically active in disease control.

The use of medicinal plants and plant-based therapies in the management of hypertension is deeply rooted in traditional medicine across many cultures. While such practices have often existed outside conventional healthcare systems, modern scientific research is now providing evidence-based explanations for their effectiveness.

While these findings are based on animal studies and cannot yet be directly translated into clinical recommendations for humans, they open the door to future research on dietary strategies that can safely complement antihypertensive drugs.

Further clinical studies are needed to determine appropriate dosages, safety profiles, and real-world effectiveness.

In the fight against hypertension, the future may lie not only in new drugs, but also in smarter combinations, where medicine and nutrition work together to deliver better, safer outcomes for patients.

Such nutrition to help maintain healthy blood pressure includes garlic, potatoes, walnuts,tomato and tomato products, legumes and citrus fruits (grapefruits and oranges).
(TRIBUNE)